This analysis revealed that high BRD4 mRNA expression was associated with poor patient survival (P = 0.001; Fig 1A) and disease‐free survival (P = 0.0008; Fig EV1) in NRAS‐mutant melanoma patients, but not in other genetic cohorts (Appendix Fig S1). The gene discussed is NRAS; the disease is melanoma.